Abstract
Objectives The United Arab Emirates responded to the SARS-COV-2 pandemic and widely implemented test-and-trace strategy. In this cross-sectional questionnaire-based study 531 subjects presenting for SARS-COV-2 testing were recruited to study population’s beliefs and choices regarding testing and were compared to 156 who never been tested.
Results The community uptake in Abu Dhabi Emirate reached 90% (average of 68% overall). In the great majority it was self-motivated as 6% only had doctor referral. Those who had not taken a test were younger in age (p < 0.001), more likely performing activities such as shopping and eating out (p = 0.001), have a medical illness (p < 0.0001), and working from home (p = 0.005). The tested group reported significantly more agreement with the statement, if someone had negative result no need to stay home or wear mask. In conclusion, SARS-COV-2 testing had extensive coverage and high acceptability in the UAE. Acting on concluded beliefs and attitude are key to ensure the testing coverage efficiency and public empowerment.
- SARS-COV-2
- attitudes
- believes
- public health
- Testing
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Nothing to declare
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Abu Dhabi Central IRB Human Ethics research Committee.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data will be available if requested.
